- Home
- MYI vs AGL Comparison
MYI vs AGL Comparison
Compare MYI & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYI
- AGL
- Stock Information
- Founded
- MYI 1992
- AGL 2016
- Country
- MYI United States
- AGL United States
- Employees
- MYI N/A
- AGL N/A
- Industry
- MYI Investment Bankers/Brokers/Service
- AGL Managed Health Care
- Sector
- MYI Finance
- AGL Health Care
- Exchange
- MYI Nasdaq
- AGL Nasdaq
- Market Cap
- MYI 767.7M
- AGL 894.1M
- IPO Year
- MYI N/A
- AGL 2021
- Fundamental
- Price
- MYI $10.96
- AGL $1.98
- Analyst Decision
- MYI
- AGL Hold
- Analyst Count
- MYI 0
- AGL 18
- Target Price
- MYI N/A
- AGL $4.38
- AVG Volume (30 Days)
- MYI 256.7K
- AGL 3.7M
- Earning Date
- MYI 01-01-0001
- AGL 11-07-2024
- Dividend Yield
- MYI 4.81%
- AGL N/A
- EPS Growth
- MYI N/A
- AGL N/A
- EPS
- MYI N/A
- AGL N/A
- Revenue
- MYI N/A
- AGL $5,594,117,000.00
- Revenue This Year
- MYI N/A
- AGL $41.65
- Revenue Next Year
- MYI N/A
- AGL $10.30
- P/E Ratio
- MYI N/A
- AGL N/A
- Revenue Growth
- MYI N/A
- AGL 54.10
- 52 Week Low
- MYI $9.32
- AGL $1.50
- 52 Week High
- MYI $11.70
- AGL $13.28
- Technical
- Relative Strength Index (RSI)
- MYI 28.60
- AGL 44.45
- Support Level
- MYI $11.43
- AGL $1.80
- Resistance Level
- MYI $11.61
- AGL $2.33
- Average True Range (ATR)
- MYI 0.13
- AGL 0.18
- MACD
- MYI -0.06
- AGL 0.00
- Stochastic Oscillator
- MYI 8.22
- AGL 33.96
About MYI Blackrock MuniYield Quality Fund III Inc
BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.